Transgenic rats expressing the pX gene of human T lymphocyte virus type-I (HTLV-I) under control of the rat lymphocyte-specific protein tyrosine kinase type-I promoter (lck-pX rats) developed benign epithelial thymomas. When the thymuses of newborn lck-pX rats were transplanted into the subcapsular space of the kidney in other thymectomized lck-pX rats, similar tumors developed in the transplanted thymuses. Following the tumor growth, dissemination in the abdominal cavity and distant metastasis occurred. The tumors were histopathologically similar to the original thymomas, but prominent nuclear atypia and high mitotic activity were present. The Ki-67 index was twice as high as that in the originals. The tumors were transplantable into the subcutis of lck-pX rats, although transplantation of the originals never succeeded. All evidence indicated that malignant transformation of thymoma was induced by the heterotopic transplantation. Expression of the pX transgene in the transformed tumors were significantly reduced. Among host genes, the expression of p16ink4a/ARF, which was significantly upregulated in the originals, was never detected in the transformed tumors. Genomic Southern blots and PCR suggest that homozygous deletion of the p16ink4a/ARF gene may play important roles in malignant transformation in this model. Our model described here is a useful unique model for in vivo malignant transformation. Laboratory Investigation (2005) 85, 851-861.
Human T lymphocyte virus type-I (HTLV-I) is the etiologic agent of adult T-cell leukemia/lymphoma (ATL/L). [1] [2] [3] Tax protein encoded by the unique pX region of HTLV-I genome is thought to play central roles in the tumorigenesis, since it could induce immortalization of human T cells 4 and transform fibroblast cell lines in vitro, 5 and transgenic animals carrying the pX gene developed several kinds of tumors in vivo. [6] [7] [8] [9] [10] Tax activates not only transcription of the viral genes but also many cellular genes, such as lymphokines, interleukin-2 receptors, c-fos, and c-jun etc., through modulation of host transcription factors, such as cAMP responsive element binding factor (CREB), nuclear factor (NF)-kB and serum responsive factor (SRF). 11 In addition, Tax inhibits functions of several cell cycle regulating proteins, such as p53, tumor suppresser protein; 12, 13 p16ink4a, inhibitor of cyclin-dependent kinases (Cdk); 14 and hsMAD1, spindle checkpoint protein. 15 Tax exerts its tumorigenicity through these pleiotropic effects on host cellular genes. 16, 17 To investigate tumorigenicity of the pX gene in lymphoid tissues, we established a transgenic rat model carrying the pX gene under control of the rat lymphocyte-specific protein tyrosine kinase (p56lck) proximal promoter. 10 In the transgenic rat model, epithelial thymomas frequently developed. Although fatal dyspnea sometimes occurred due to expansive growth of the thymomas in the thoracic cavity, the tumors never invaded to neighboring organs or metastasized, indicating a benign behavior.
In the present study, we induced in vivo malignant transformation of the epithelial thymomas by heterotopic transplantation of the thymuses from newborn lck-pX rats into the subcapusular space of kidneys of other lck-pX rats which had been undergone thymectomy, and compared the biological and molecular characteristics between the original and transformed tumors to better understand the roles of the pX gene in tumorigenesis in vivo.
Materials and methods

Rats
Inbred male Fisher 344/jcl rats (F344 rats) were purchased from Clea Japan (Osaka, Japan). The Tg38 line of lck-pX rats, which established in F344 strain and frequently had thymomas, 10 was maintained at the Institute for Animal Experimentation, Hokkaido University Graduate School of Medicine, and was used in this study. All animal experiments were performed according to the Guide for the Care and Use of Laboratory Animals in Hokkaido University Graduate School of Medicine (http://www.hokudai. ac.jp/animal/houki/hokudaisisin.html).
Histopathology and Immunohistochemistry
Tissues from lck-pX and nontransgenic F344 rats were fixed in 10% phosphate-buffered formaldehyde and embedded in paraffin blocks. Each 4 mm section was stained with hematoxylin and eosin (HE). For Ki-67 immunostaining, sections were autoclaved for 10 min at 1201C and then reacted with mouse anti-rat Ki-67 monoclonal antibody (DAKO, Glostrup, Denmark). Specific staining was detected using an LSAB2 kit (DAKO). Nuclei with positive staining for Ki-67 were counted in 10 highpower ( Â 400) fields of each sample. Any nuclear staining, regardless of its intensity, was considered to be positive. Ki-67 staining index was expressed as percentage of the positive nuclei.
Transplantation of Thymus into the Subcapsular Space of the Kidney
Thymuses were extirpated from newborn lck-pX rats and then chopped into small fragments. The fragments were transplanted into the subcapsular space of bilateral kidneys of lck-pX rats (6 weeks old) at 1 week after thymectomy. Right and left lobes of the thymus from one donor were transplanted into bilateral kidneys, respectively, of one recipient. Totally, 5 times of independent transplantation were performed.
Tumor Transplantation into the Subcutis of lck-pX Rats
About 25 mm 3 of tumor tissues were cut into small fragments in 5 ml Hanks' balanced salt solution (HBSS) (Invitrogen, Co., Carlsbad, CA, USA). The fragments in 0.5 ml HBSS were injected into the subcutis of bilateral back of lck-pX rats (7 weeks old). The tumor from one donor was transplanted into one recipient rat. Totally, 3 times of independent transplantation were performed. At 3 months after the injection, tumor formation was macroscopically and microscopically evaluated. Recipient rats used in this experiment had not been given thymectomy. Since it was considered that Tax (protein product of the pX transgene) would be recognized by immune systems in nontransgenic recipients, lck-pX rats served as recipients in our transplantation experiments.
Nucleic Acid Isolation
Tumors and thymuses from lck-pX and nontransgenic F344 rats were snap-frozen in liquid nitrogen prior to isolation of RNA and DNA. Before being frozen, thymocytes were disaggregated by rinsing the thymuses, the surface of which had been cut, in HBSS. It was histologically confirmed that over 90% of thymocytes were removed. Total RNAs were isolated using ISOGEN reagents (Nippon Gene, Toyama, Japan) and genomic DNAs were isolated by the standard phenol-chloroform extraction. All samples were microscopically confirmed to be the target tissues.
Real-Time Quantitative Reverse Transcriptase-Polymerase Chain Reaction
Complementary DNAs were synthesized from total RNAs using 2 mg of DNaseI (TAKARA Shuzo, Co., Kyoto, Japan), a random primer set (TAKARA Shuzo, Co.) and Moloney murine leukemia virus RT (Invitrogen, Co.). Real-time quantitative reverse transcriptase-polymerase chain reaction (RT-PCR) was performed using the ABI PRISM 7900 Sequence Detection System (Applied Biosystem, Foster City, CA, USA) with SYBR Green I as a double strand DNA-specific binding dye, and the reaction was continuously monitored based on the fluorescence levels, according to Wittwer et al. 18 Each cDNA was amplified using QuantiTect SYBR Green Master Mix (QIAGEN, Hilden, Germany) containing 0.3 mM of the specific primers for each gene in a total volume of 10 ml, according to the following PCR conditions: 951C for 15 min, followed by 45 cycles of 941C for 30 s and 601C for 30 s and 721C for 1 min. Melting curve analysis was performed at the end of each reaction, after which absence of primer dimmers was confirmed. Standard curves for each gene were generated from a serially diluted cDNA mixture that consisted of cDNAs from five discrete samples. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was used as a control for the amount of RNAs. Each reaction was performed in triplicate to calculate the average and standard deviation. Primer sets used are listed in Table 1 .
Southern Blotting
In all, 20 mg of genomic DNAs from each sample digested either with HindIII, BamHI or EcoRI was electrophoretically separated on a 0.8% agarose gel and transferred to a Hybond N þ membrane (Amersham Pharmacia Biotech., Buckinghamshire, UK) using the standard capillary method. The digoxygenin (DIG)-labeled cDNA probes were prepared by PCR amplification. Briefly, 1 mg of cDNAs from a normal rat thymus was amplified in a total of 50 ml solution containing 1 mg cDNA template, 70 mM DIG-11-dUTP (alkali-label), 130 mM dTTP, 200 mM dATP:dGTP:dCTP, 5 mM MgCl 2 , 5ml 10Â PCR buffer II, 3.75 U AmpriTaq Gold (Roche Diagnostics, Mannheim, Germany), and the primer set for the rat p16ink4a gene, sense (5 0 -CATCTCCGAGAGGAAG GCG-3 0 ) and antisense (5 0 -TCTCGCGTTGCCAGAA GTG-3 0 ). After denaturing at 1001C for 5 min, the DIG-labeled probe was hybridized to the membrane in DIG Easy Hyb (Roche Diagnostics) at 451C overnight. Next, the membrane was washed twice in 2 Â SSC solution (1 Â SCC: 0.15 M sodium citrate, 15 mM citric acid, pH 7.0) that contained 0.1% sodium dodecyl sulfate (SDS) at room temperature for 15 min, and then washed twice in 0.5 Â SSC and 0.1% SDS at 651C for 15 min. Hybridized probes were visualized by chemiluminescense using anti-DIG-F(ab) conjugated with alkaline phosphatase (Roche Diagnostics) and CDP-star (New England Biolabs, Beverly, MA, USA) as a TIFF format image using Fluor-S MultiImager (Bio-Rad Laboratories, Hercules, CA, USA). Densities of bands with specific hybridization were calculated using Scion image software (Scion, Co., Frederick, MD, USA). After dehybridization, the membrane was rehybridized with the rat Rb probe prepared using the same procedure described and the primer set, sense (5 0 -GGAGCACAGCGATAT AAACTTGG-3 0 ) and antisense (5 0 -CTGCTTGCGT CTCTGTATTTGC-3 0 ), as a control.
In Vitro Cell Cloning from the Transformed Tumors and Genomic PCR Tumors with malignant transformation, which developed in recipient rats, were cut into small fragments in HBSS, then placed onto Petri dishes and cultivated in Dulbeccos modified Eagle's medium (Invitrogen, Co.) supplemented with 10% fetal bovine serum for 1 week. After two passages, adherent tumor cells were stripped with trypsin-EDTA solution, and then cloned using the limiting dilution method (0.3 cells/well) in 96-well plates. In all, 200 ng of genomic DNAs extracted from the cloned cells was used as templates for PCR with the primer sets for the p16ink4a/ARF, similar to 5-methylthioadenosine phosphorylase (MTAPase), and Rb genes (see Table 2 ). The PCR was performed in a total of 20 ml solution, containing DNA template, 
Karyotype Analysis
Chromosomes of cells separated from the original and transformed thymomas were analyzed, according to Wang and Fedoroff. 19 A total of 17 and 18 cells from both original and transformed thymomas were analyzed, respectively.
Results
Development of Thymomas with Malignant Phenotypes in Heterotopically Transplanted lck-pX Thymuses in the Subcapusular Space of Recipient Rat Kidney
At 3 months after the thymus transplantation, tumors developed in the transplanted thymuses in the subcapusular space of the recipient lck-pX rat kidney (Figure 1a) . Histologically, tumors were composed predominantly of spindle-shaped cells, and these cells showed medullary growth with storiform and whirly patterns (Figure 1b) . Immunohistochemically, tumor cells were positive for cytokeratin (data not shown). These were the same histopathological features as original thymomas in lck-pX rats. 10 Abdominal distention in recipient rats became evident from 6 months after the transplantation. In these rats, large tumors with ascites were found in contact with the kidney, and peritoneal disseminations and distant metastases to the lungs and liver were evident (Figure 1c, d ). These phenotypes indicated that the tumors were highly malignant. This phenomenon was observed in all cases where heterotopic transplantation had been performed (n ¼ 5).
Microscopically, the tumor cells had larger nuclei and showed more prominent nuclear atypia compared to the original thymomas (Figure 1e, f) . Distinct nucleoli were evident and mitotic activity was high (Figure 1e ). The Ki-67 immunoreactivity, which assesses the proliferative activity of tumor cells, was significantly higher and stronger than that seen in the original thymomas (Figure 1g, h) . Mean values and standard deviations of Ki-67 staining indices were 55.877.1% in thymomas with malignant transformation (n ¼ 5) and 25.974.3% in original thymomas (n ¼ 9), with a statistical significance (Po0.001) (Figure 1i) .
To assess the biological malignancy, tumor tissue fragments were injected subcutaneously into lck-pX rats. In all rats injected with the transformed thymoma tissues (n ¼ 3), tumors in the subcutis rapidly grew within 1 month (Figure 2a) . On the other hand, tumor formation never observed in any rat injected with the original thymoma tissues (n ¼ 6) (Figure 2b ) until 3 months after the injection, both macroscopically and microscopically (data not shown). 20 we mainly quantified the expression levels of genes associated with these pathways. In Figure 3 , HTLV-I pX, which is a transgene, was detected at high levels in the original thymomas, but at low levels in the transformed thymomas similar to what were seen in the tumor-free thymuses of lck-pX rats. No expression of p16ink4a and ARF was evident in the thymomas with malignant transformation, although these expressions were consistently high in the originals. Expression of cyclin D2 showed a pattern similar to that seen in HTLV-I pX. These alterations in gene expression levels in the transformed thymomas were significant. Although no significant difference was evident, expression levels of Cdk4 and mdm2 tended to be low in the thymomas with malignant transformation compared with those of the originals, and cyclin D3, GADD45 and Rb genes in both types of thymomas were expressed at low levels compared with those of the tumor-free thymuses of lck-pX rats.
Gene Expression Levels in the
Original and Transformed Thymomas, Using Real-Time Quantitative RT-PCR To compare the transcription levels of genes between the original and transformed thymomas, real-time quantitative RT-PCR was performed. Since abnormalities of p53 and Rb pathways were reported to play important roles in tumorigenesis of many human malignancies including ATL,
Genomic Analysis of the p16/ARF Locus in the Transformed Thymomas
To determine why the expressions of p16ink4a and ARF disappeared with malignant transformation, we analyzed the genome of cells with malignant transformation. Normal rat karyotype 42XY was seen in the original thymomas, 21 but several alterations in karyotype were evident in the cells with malignant transformation (eg 41XY, À10). However, no homozygous alteration in karyotype was evident on chromosome 5 that codes the p16ink4a/ARF locus in rats. For a further assessment, genomic Southern blot analysis with three different restriction enzymes (HindIII, BamHI and EcoRI) was performed using the p16ink4a cDNA probes. Regardless of the restriction enzyme, there was no difference in banding patterns among the transformed and original thymomas and the thymus of a nontransgenic rat (Figure 4a ). However, densities of all bands in the transformed thymomas were significantly low compared with those of the original thymomas and the nontransgenic thymus. Each density of the HindIII digested band in genomes of three transformed thymomas tested was low (10.3, 22.7 and 19%, respectively) compared with that of the normal rat genome when the density was calculated based on that of the 
Malignant transformation of thymoma in rats T Tsuji et al
nonaffected Rb gene in each sample (Figure 4b ). Since samples contained nontumor tissues, such as vascular and other mesenchymal components, it was suggested that the p16ink4a/ARF locus might be homozygously deleted in the thymomas with malignant transformation. No significant difference in the density of p16ink4a bands was found between the original thymomas and the nontransgenic thymus. To confirm homozygous deletion of the p16ink4a/ARF locus in the transformed thymomas, we established cell clones from the disseminated tumor (used in Figure 4b , lane 7) and analyzed by genomic PCR using the primer set for the p16ink4a exon 1a. No band corresponded to the p16ink4a exon 1a was amplified in all three cell clones tested, although the band corresponded to the Rb gene was evident at the same levels as that seen in a control rat genomic DNA ( Figure 5 ). Rat p16ink4a/ARF gene is composed of exons 1b, 1a, 2 and 3, followed by the gene similar to 5-MTAPase (Figure 6a ). When we Figure 1 Continued.
Malignant transformation of thymoma in rats
T Tsuji et al examined the genomic DNA of cloned cells from malignant thymoma, the exon 1b but not 2 or 3 was detected by PCR (Figure 6b ). The gene similar to 5-MTAPase located in the downstream of the p16ink4a gene was detected, suggesting that the deletion of chromosome 5 included the exons 1a, 2 and 3 of the p16ink4a gene in malignant thymomas.
Discussion
Although benign epithelial thymomas developed in lck-pX rats, no other disease or abnormality, such as malignancy of lymphocytes or immunological dysfunction etc, was observed because fatal dyspnea occurred due to expansive growth of the tumors in the thoracic cavity when young. 10 To determine if thymomas can develop in a heterotopic situation in lck-pX rats, and acquire a long survival model carrying thymomas, we carried out heterotopic transplantation of lck-pX thymuses from newborns. Prior to RNA isolation, thymocytes were disaggregated by rinsing the thymuses, the surface of which had been cut, in HBSS. It was histologically confirmed that over 90% of thymocytes were removed. Expression levels of GAPDH were used for standardization of levels of each gene expression. Ratios to the expression levels of GAPDH in each sample are shown. Each column corresponds to an individual rat. Data are shown as mean7standard deviation on the basis of experiments performed in triplicate.
Malignant transformation of thymoma in rats T Tsuji et al
The thymuses were transplanted into the subcapsular space of the kidney of other lck-pX rats that had been undergone thymectomy, where formation of new blood vessels is easily introduced into the grafted tissues. 22 At 3 months after the transplantation, tumors with the same histological features as the original thymomas in lck-pX rats occupied the transplanted thymus in the recipient kidney, indicating that thymomas can also develop at heterotopic sites if there is a thymic tissue.
Interestingly, additional 3 months incubation could induce malignant transformation of thymomas. Similar malignant transformation was observed at a shorter period when the original thymomas were transplanted into the subcapsular space of the kidney (unpublished data). These findings indicated that thymomas with a benign behavior developed in the transplanted thymuses, then malignant transformation occurred through an additional incubation period. Since we never found a malignant transformation of original thymomas (n4100) in the thoracic cavity, 10 environmental factors might be critical for the malignant transformation. Fidler 23 noted that tumors could receive nutrients by diffusion when they were as small as 1-2 mm in diameter, but the angiogenesis was indispensable for bigger growth and to become aggressive and invasive. The subcapsular space of the kidney may be a suitable site for tumor aggression where vascularization into the grafted tissues is easily introduced. 22 Actually, when tumor cells from the renal cell carcinoma were injected into subcutaneous, intraperitoneum, intravein or beneath the renal capsule of nude mice, a remarkable metastasis was observed only in cases where the cells were inoculated into the subcapsular space of the kidney. 24 In line with this, the thymomas could develop and become malignant with aggressive growth in the subcapusular space of the kidney, although development of a tumor was never found when original thymomas were transplanted into the retroperitoneal subserosal space (unpublished data).
The most remarkable differences in host gene expressions related with p53 and Rb pathways between original and transformed thymomas were the expression of p16ink4a and ARF genes. The p16ink4a and ARF are distinct tumor suppressor genes that share a common exon but encode nonhomologous proteins. 25 Abnormalities of the p16ink4a/ARF locus were noted in 30-60% of human malignancies, such as esophageal carcinomas, gliomas, mesotheliomas and ATL. 26, 27 There was a report on the high expression of p16ink4a in HTLV-I-infected cell lines. 28 The HTLV-I pX gene product, Tax, which can trans-activate various cellular genes and is the most pathogenic factor of 4, and 7) , and original (lanes 2, 5, and 8) and transformed thymoma tissues (lanes 3, 6, and 9) were digested with HindIII (lanes 1-3) , BamHI (lanes 4-6) and EcoRI (lanes 7-9), then Southern hybridization was performed using the p16ink4a cDNA probe. Prior to RNA isolation, thymocytes were disaggregated by rinsing the thymuses, the surface of which had been cut, in HBSS. It was histologically confirmed that over 90% of thymocytes were removed. The lower panel: the Rb cDNA probe was used as a control for amounts of applied DNA samples. 
Malignant transformation of thymoma in rats
T Tsuji et al HTLV-I, 11 increases the expression of cyclin D2 as an activator of the transcriptional factor, E2F, and suppresses the function of p16ink4a as an inhibitor of Cdk 4/6, which activate E2F together with cyclin D2 by protein-protein interaction, thus suggesting that the cell cycle may be deregulated in cells expressing Tax protein.
14 In original thymomas, the high levels of p16ink4a expression may control the tumor growth with aberrant expressions of the pX gene and cyclin D2 gene trans-activated by Tax, and may suppress at least malignant cell transformation. Therefore, it seems likely that loss of the p16ink4a expression in the transformed thymoma cells induced a more prominent growth, although levels of the pX expression in the malignant thymomas were less than a half of that in the originals. ARF, which is activated by E2F, 29, 30 increases the functional potency of p53 by neutralization of mdm2 oncoprotein (a suppressor of p53) activity. 31 Although the expression of ARF was at high levels in the originals and was lost in the malignant thymomas, the p53 gene may not be critical for the benign to malignant transformation in our model, because no significant difference in the expressions of p53 and its target genes, such as GADD45, p21, mdm2, and bax, was seen between the original and transformed thymomas. Tolbert et al 32 reported that ARF deficiency had no impact on functions of p53 and its related molecules in the transgenic brain tumor model. ARF-dependency of p53 and its related molecules may vary in cell types. However, some functions of p53 repressed by Tax 12,13 might relate HTLV-I tumorigenesis in thymomas of lck-pX rats, because the expression levels of GADD45, one of the p53 target genes, were significantly suppressed not only in the transformed thymomas but also in the originals.
To clarify the loss of p16ink4a/ARF expression, chromosomal and genomic analyses were performed. Although several chromosomal abnormalities were evident in the transformed thymomas, no homozygous abnormality was found in chromosome 5, which encoded the p16ink4a/ARF locus in karyotype analysis. However, genomic Southern blots and PCR using the primer sets specific for the p16ink4a/ARF gene and its downstream gene similar to 5-MTAPase indicated homozygous deletion of the p16 locus in the transformed thymomas. The deletion of chromosome 5 included the exons 1a, 2, and 3 of the p16ink4a gene in malignant thymomas. These findings corresponded to the fact that the deletion was not recognized by the karyotype analysis. A similar deletion was found in some human squamous cell carcinomas of the head and neck. 33 It seems likely that a certain site where the genome is liable to be lost in the p16ink4a gene, and this may be associated with malignant transformation of some kinds of tumors. Generally, inactivation of p16ink4a is caused by homozygous deletions, methylations of the promoter or point mutations, and the frequencies and patterns of p16ink4a inactivation are different depending on the origins of tumors. 34 In cases of ATL, not only homozygous deletion of p16ink4a 27,35 but also Expression levels of the pX gene, the most pathogenic factor of HTLV-I, were significantly lower in the malignant thymomas than those in the originals, and were similar to tumor-free thymuses in lck-pX rats. Although the reason for this decrease of the pX expression in malignant thymomas remains unclear, it was functionally confirmed by the decrease of cyclin D2 expression that is directly controlled by Tax through an NF-kB-like element and a CRE-like element residing in the promoter. 37 Therefore, it was suggested that the pX expression was not essential for growth of the thymomas after malignant transformation. In line with this, the defective proviruses, which could not express intact Tax, were frequently detected in the aggressive form of ATL, such as acute-type and lymphoma-type ATL. 38, 39 The collecting evidence suggests that the aggressive form of tumor cells may not require the expression of pX gene for further growth, once they have reached to the state of a high malignancy with alteration of host genes for regulation of the cell cycle, such as p16ink4a/ARF. Moreover, loss of Tax on the tumor cells may lead to an escape from immune systems of the host, because Tax is a major target of cytotoxic T lymphocytes. 40 Since Tax has mutagenic effects on cellular genes 41 and the subcapsular space of the kidney provides a better environment, including the potential of vascularization and larger space limits than the thorax, for cell division of tumors with aberrant expression of Tax, accumulation of mutations of genes, including key molecules such as p16ink4a/ARF, may facilitate malignant transformation in thymomas with a benign behavior.
ATL can be classified into four clinical subtypes: chronic, smoldering, acute and lymphoma type. 42, 43 The progression from indolent ATL (chronic and smoldering type) to aggressive ATL (acute and lymphoma type) is sometimes observed, and it is also known that abnormalities of p16ink4a and p53 frequently accompany this progression. 27, 35, 43 Therefore, the malignant transformation seen in our animal model might correspond to the progression of ATL in humans. The in vivo model for malignant transformation described here appears useful for understanding the mechanism of malignant progression not only in ATL but also in other general benign tumors.
